Breckenridge Pharmaceuticals, Metabolite Labs, and Pamlab Sue Macoven Pharmaceuticals

  • December 14, 2011

Breckenridge Pharmaceuticals, Metabolite Labs, and Pamlab filed suit against Macoven Pharmaceuticals over a patent related to compositions for preventing or reducing elevated metabolic levels.  12/9, Southern District of New York, 1:2011cv09022.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×